Currently, it is not approved by the US Food and Drug Administration, so doctors can't prescribe it and pharmacies can't sell it
Several clinical studies have shown that chronic treatment with liraglutide delays gastric emptying [10, 19, 39]
Yet despite these benefits, some patients taking GLP-1 medications report serious gastrointestinal issues (such as gastroparesis and bowel obstruction) and, in other cases, vision injuries claims that now form the backbone of ongoing litigation
Should this be treated in the emergency department
Trends Endocrinol Metab 25(1):4252 Nwia SM, Li XC, Leite APdO, Hassan R, Zhuo JL (2022) The Na+/H+ exchanger 3 in the intestines and the proximal tubule of the kidney: localization, physiological function, and key roles in angiotensin II-induced hypertension